hematopoietic system
|
|
• partial arrest of B cell development
(J:28968)
|
|
|
• defective B cell activation after immunization with T-independent type II antigens
(J:28968)
|
|
|
• in vitro, B cells show a reduced level of proliferation in response to LPS compared to wild-type
(J:82298)
|
|
|
• increased numbers of pro-B cells
(J:28968)
|
|
|
• decreased numbers of mature B cells
(J:28968)
• numbers of mature recirculating B cells (B220highIgM+, HSAlowIgM+, and B220+IgD+) are reduced
(J:82298)
|
|
|
• germinal centers are infrequent in TNP-LPS immunized mutants
(J:82298)
|
|
|
• germinal centers are smaller in TNP-LPS immunized mutants
(J:82298)
|
immune system
|
|
• partial arrest of B cell development
(J:28968)
|
|
|
• defective B cell activation after immunization with T-independent type II antigens
(J:28968)
|
|
|
• in vitro, B cells show a reduced level of proliferation in response to LPS compared to wild-type
(J:82298)
|
|
|
• increased numbers of pro-B cells
(J:28968)
|
|
|
• decreased numbers of mature B cells
(J:28968)
• numbers of mature recirculating B cells (B220highIgM+, HSAlowIgM+, and B220+IgD+) are reduced
(J:82298)
|
|
|
• germinal centers are infrequent in TNP-LPS immunized mutants
(J:82298)
|
|
|
• germinal centers are smaller in TNP-LPS immunized mutants
(J:82298)
|
|
|
• smaller and fewer germinal centers are observed in response to TI-I antigen, TNP-LPS
(J:82298)
|
|
|
• decreased serum IgG3 concentration
(J:28968)
(J:82298)
|
|
|
• decreased serum IgM concentration
(J:28968)
(J:82298)
|
cellular
|
|
• partial arrest of B cell development
(J:28968)
|
|
|
• defective B cell activation after immunization with T-independent type II antigens
(J:28968)
|
|
|
• in vitro, B cells show a reduced level of proliferation in response to LPS compared to wild-type
(J:82298)
|
|
|
• increased numbers of pro-B cells
(J:28968)
|
Mouse Models of Human Disease |
OMIM ID | Ref(s) | |
| Agammaglobulinemia, X-Linked; XLA | 300755 | J:28968 | |
